Skip to main content


Editor's pick

TNF inhibitors unlikely to raise cancer recurrence risk in RA patients


Treatment with tumour necrosis factor inhibitors is not associated with a significantly increased risk of recurrent cancer among patients with rheumatoid arthritis, researchers report.


17-08-2018 | Rheumatology | News | Article

Intensive treatment in early arthritis patients provides long-term remission benefits

Short-term induction therapy with a tumor necrosis factor inhibitor plus methotrexate could alter disease development in some patients with early rheumatoid arthritis, providing long-term benefit, results of the DINORA trial suggest.


Arthritis Res Ther 2018; 20: 174

16-08-2018 | Rheumatology | News | Article

Predictors of remission in RA patients identified

Two studies have described factors associated with the achievement of sustained remission among patients with rheumatoid arthritis.


Rheumatology 2018; doi:10.1093/rheumatology/key202
Arthritis Res Ther 2018; 20: 165

15-08-2018 | Rheumatology | News | Article

Further evidence for the benefits of febuxostat in gout patients with renal impairment

Results of a phase III trial indicate that both the immediate and extended release formulations of febuxostat reduce serum uric acid levels in patients with gout, including those with impaired renal function.


Arthritis Rheumatol 2018; doi:10.1002/art.40685

13-08-2018 | Rheumatology | News

News in brief

Integrated dermatology–rheumatology clinic may improve PsA management

Collaboration between rheumatologists and dermatologists in a combined clinic may help improve outcomes for patients with psoriatic arthritis, study results suggest.

Twitter Icon Follow medwireNews

Click here
image credits